Hao Wu
A Higher Order
Boston Children's Hospital
Published May 30, 2019
Hao Wu is a third generation scientist whose formative years were shaped by the Chinese Cultural Revolution. In fact, it’s fair to say the revolution, better known for persecution of academics and intellectuals, gave an unlikely boost to her future career.
Wu’s parents were physicists, and her grandfather was a chemist for the previous government. Her father’s older siblings had emigrated to the United States. It all added up to a family judged as enemies to the revolution. In Beijing, young Wu was bullied by her peers. Her parents were ordered to the countryside to farm rice and raise pigs. They sent Wu to live with her aunt in another town until they all returned to Beijing two years later.
Against that backdrop, school became more important, both as a retreat and for positive feedback, especially in math and science, at which she excelled.
Now at Boston Children’s Hospital and Harvard Medical School (HMS), Wu’s laboratory has added a new dimension to the way people think about the molecular signaling that fires up the immune system in illness and in health.

Hao Wu in her laboratory at Boston Children's Hospital.
Her interest in immunology began at Peking Union Medical College, where she landed in a lab that researched the autoimmune disease lupus. A lecture she heard by Purdue University structural biologist Michael Rossmann at a meeting in Beijing sealed her fate. X-ray crystallography seemed a perfect marriage of math and physics, with biological applications.
Wu joined Rossmann’s lab in Indiana and completed her PhD in 1992. She continued as a postdoctoral fellow in Wayne Hendrickson’s laboratory at Columbia University. By then, HIV/AIDS had become the leading cause of death for U.S. men aged 25 to 44 years and was on its way to becoming a global pandemic.HIV/AIDS research greatly advanced understanding of basic immunology, and Wu’s project was no exception. The virus enters and destroys T cells after binding to CD4, which normally acts to help activate T cells to fight infections. Wu solved the full four-domain extracellular structure of CD4. In the process, she found the CD4 doubles up for binding, forming a dimer on the surface, forming a foundation for immune signaling.
In 1997, Wu started her own lab at Weill Medical College of Cornell University. Now she needed something to study and a long-term research plan. “I buried myself in the library,” Wu says. “What came to me was TNF, a cytokine whose intracellular signaling pathway was just being discovered.”
In her reading, Wu also found an intriguing link between TNF and a pioneering physician with a connection to her new workplace, once known as New York Hospital. In the late 1800s, William Bradley Coley experimented using bacterial infections to treat cancer, which is thought to be the original immunological cancer therapy.
No one knew how “Coley’s toxins” worked at the time, but decades after Coley’s death, researchers identified TNF as one of the immune responses that likely induced tumor cell death. The story reminded Wu of anecdotes she had heard growing up about people cured of their cancers by high fever or infections.
At Weill, Wu and her technician began the long process of expressing proteins and growing crystals for their first project: A structure of the first step in the TNF signaling process. TNF binds to a receptor on the surface of innate immune cells, triggering the receptor’s tail inside the cells to bind TRAF (short for TNF receptor associated factors). The TRAF family were the major signaling proteins for TNF receptors, but no structural information was available at the time.
A postdoctoral fellow soon arrived, and within a year they submitted their first paper to Nature. It was rejected.
“I was of course very worried,” Wu recalls. When she showed it to her postdoctoral advisor, Hendrickson interpreted the reviewers’ comments: The TRAF2 structure is nice, but it would be nicer in complex with the receptor. Wu’s small team performed the work and resubmitted. The paper sailed through and was published in 1999.
“It is true you learn more about the protein in a complex,” Wu says. That was an understatement, she would soon learn.
Based on classical receptors, scientists have envisioned signaling inside cells as a chain of events, transmitting signals from the outside to the inside of cells. A receptor undergoes conformation change, leading to a signaling enzyme, second messenger, and then a cellular response.
But as Wu began to work out more details of TNF signaling, she found something quite different. The innate immune system acts more like a flash mob or a pop-up event. Many proteins come together in higher-order aggregates for specific purposes.
“For innate immune receptors, it appears ligand binding induces formation of large assemblies—including the receptors, the intracellular adaptor proteins, signaling enzymes, as well as substrates—all into these gigantic complexes which mediate both signal transduction across cell membranes and signal amplification,” says Wu.
The higher-order picture first emerged in efforts to obtain crystal structures of death domain proteins, which activate apoptosis if the TRAF2 cell survival process is inhibited. The first paper, published in 2007 in Cell, was a 12-molecule complex that finally yielded a crystal for collecting data.
Analysis of the data was equally challenging, because Wu and her colleagues could not find traditional symmetries to identify where one molecule ended and the other began. The lightbulb went off in trying to understand another death domain complex published in Nature in 2010.

“That was the point when we realized these proteins can all form assemblies through helical symmetry, like DNA,” Wu says. In other words, the working molecules spoon each other, some in spiral staircase formations.
The helical assembly opened Wu’s mind to other possibilities. Francis Chan at Duke University asked Wu’s lab to work on a necrosome they discovered, a protein complex that brings on a cell death of last resort, if apoptosis is inhibited.
The disordered protein sequences told her the necrosome complex wouldn’t crystallize. She saw hints of beta strands. Confirming her hunch, the necrosome assembled into a functional amyloid signaling complex composed of beta sheets, they reported in Cell in 2012.
Proteins that form helical assemblies often result in long filaments that could not make crystals. That launched Wu on a journey to learn electron microscopy (EM).
In 2009, she spent a short sabbatical in the HMS lab of Tom Walz working on single particles. In 2012, she approached multiple people about collaborating on cryo-EM. Finicky experimental samples were the death knell of an effort with Nikolaus Grigorieff at Brandeis University, also in the Boston area.
Problematic test samples almost torpedoed another collaboration on inflammasomes with Ed Egelman of University of Virginia. Then he took the samples to the Netherlands headquarters of Titan, makers of the transmission electron microscope. “Suddenly we had a structure,” Wu says. “We couldn’t believe it. We were beginning to see the light at the end of the tunnel, that we can use cryo-EM to address these structures.”
In 2013, the “resolution revolution” in cryo-EM launched with a paper from the lab of Yifan Cheng at University of California, San Francisco. When the first author, Maofu Liao, was recruited to HMS, Wu grabbed the opportunity to set up some collaborations with Liao, completing her self-ordered training in cryo-EM.. “All the cryo-EM people were so busy,” she says. Now, Wu’s lab does most of the cryo-EM structural determinations themselves.
Wu takes a long view. “The reason most projects in my lab have worked is not from one person,” she says. “One person may have worked on it and hit a wall, and it dropped to the back burner. A new idea comes along. It could be the same person or another. There are lots of circular things going on.”

Her lab is venturing into light microscopy to visualize the assembly of the higher order assemblies in time and space. In another direction, Wu wants to translate some of the structural insights into therapeutics. She and other colleagues at Harvard and elsewhere have formed a company called SMOC Therapeutics, referring to supramolecular organizing centers. “When I first started, I really just wanted to understand how these things work, how they come together,” she says. “As I grow older, the aspect of trying to do good for patients becomes more important.”
-- Carol Cruzan Morton
Other tales
-
Mind and Muscle
Ryan Hibbs
Published 28 March 2025
The Shapes of Energy
Luke Chao
Published 12 December 2024
-
Predicting Proteins
Jens Meiler
Published 25 November 2024
Death Metal
Steven Damo
Published 28 April 2024
-
Context Matters
Bing Chen
Published 30 January 2024
The Crystal Whisperer
Sarah Bowman
Published 29 November 2023
-
Data in Motion
Nozomi Ando
Published 29 September 2023
The Monstrous Maw
André Hoelz
Published 28 June 2023
-
Second Takes
Andrea Thorn
Published 28 February 2023
Radical reactions
Yvain Nicolet
Published 31 January 2023
-
Floppy Physics
Eva Nogales
Published 30 November 2022
Structure of Equity
Jamaine Davis
Published 28 September 2022
-
Life and Death of a Cell
Evris Gavathiotis
Published 28 July 2022
Follow the glow
Kurt Krause
Published 29 April 2022
-
Resolution solutions
Willy Wriggers
Published 25 February 2022
Of enzymes and membranes
Ming Zhou
Published 28 October 2021
-
Step-by-step
Gabrielle Rudenko
Published 26 September 2021
Moving muscle
Montserrat Samso
Published 26 July 2021
-
Particle catcher
Stefan Raunser
Published 28 June 2021
Designer drugs
Ho Leung Ng
Published 25 February 2021
-
Right place, right time
Ernesto Fuentes
Published 29 January 2021
Shape-shifting secrets of membranes
James Hurley
Published 27 November 2020
-
Enzymatic action
Cynthia Wolberger
Published 28 September 2020
Rules of motion
Priyamvada Acharya
Published 31 July 2020
-
Cosmic Squared
Michael Cianfrocco
Published 27 June 2020
Kaps are Cool
Yuh Min Chook
Published 28 April 2020
-
Spiraling into focus
Carsten Sachse
Published 29 March 2020
Seeing cilia
Alan Brown
Published 27 February 2020
-
For the Love of EM
Guy Schoehn
Published 27 January 2020
Protein Puddles
Michael Rosen
Published 16 December 2019
-
Changing channels
Daniel Minor Jr.
Published 27 September 2019
Listening Tips
Marcos Sotomayor
Published 30 July 2019
-
Beyond Cool
Published 31 May 2019
Hao Wu
A Higher Order
Published 30 May 2019
-
Aye Aye Captain
Alexandre Bonvin
Published 29 April 2019
The PARP Family Family
John Pascal
Published 28 February 2019
-
Frame by frame
Nikolaus Grigorieff
Published 28 January 2019
Predicting Success
Bil Clemons
Published 18 December 2018
-
Curiouser and Curiouser
Ramaswamy Subramanian
Published 27 November 2018
Rely on This
Sjors Scheres
Published 26 October 2018
-
Proteins out of bounds
Gerhard Wagner
Published 27 September 2018
Hiding in plain sight
Gaya Amarasinghe
Published 27 July 2018
-
Jumping Genes
Orsolya Barabas
Published 27 June 2018
Data Whisperer
Karolin Luger
Published 30 May 2018
-
Flipping the Switch
Jacqueline Cherfils
Published 27 April 2018
Tooling Around
Andrew Kruse
Published 29 March 2018
-
Comings and Goings
Tom Rapoport, Ph.D.
Published 23 February 2018
Transcriptional Rhythm
Seth Darst
Published 27 January 2018
-
The Language of Gene Regulation
Daniel Panne
Published 21 November 2017
Not Your Average Protein
James Fraser
Published 23 October 2017
-
Message Received
Sebastien Granier
Published 24 August 2017
Resistance is Futile
Celia Schiffer
Published 28 July 2017
-
Twist of Fate
Leemor Joshua-Tor
Published 28 June 2017
Drug Designer
John Buolamwini
Published 30 May 2017
-
Mathematically Minded
James Holton
Published 28 April 2017
Garbage Out
Kay Diederichs
Published 30 March 2017
-
Fixer Upper
Brandt Eichman
Published 27 February 2017
Mobilizers
Phoebe Rice
Published 31 January 2017
-
Escape Artist
Katya Heldwein
Published 19 December 2016
Nature’s Confectioner
Jochen Zimmer
Published 29 November 2016
-
State of Fusion
Jason McLellan
Published 27 October 2016
Here Be Dragons
Brian Fox
Published 28 September 2016
-
SBGrid Assumes Ownership of PyMOLWiki
Published 15 September 2016
Pharm Team
Oleg Tsodikov
Published 24 August 2016
-
Spiro-Gyra
Alejandro Buschiazzo
Published 27 July 2016
Turning the DIALS
Nicholas Sauter
Published 29 June 2016
-
Pipeline Dreams
Bridget Carragher and Clint Potter
Published 26 April 2016
U-Store-It
The SBGrid Data Bank provides an affordable and sustainable way to preserve and share structural biology data
Published 28 March 2016
-
Big Questions, Big Answers
Jennifer Doudna
Published 22 February 2016
Not a Structural Biologist
Enrico Di Cera
Published 17 December 2015
-
Divide and Conquer
Kevin Corbett
Published 19 November 2015
Computing Cellular Clockworks
Klaus Schulten
Published 23 October 2015
-
Trans-Plant
Gang Dong
Published 26 September 2015
Keep on Moving
James Berger
Published 23 August 2015
-
Totally Tubular
Antonina Roll-Mecak
Published 27 July 2015
From Disorder, Function
Julie Forman-Kay
Published 29 June 2015
-
Into Alignment
Geoff Barton
Published 27 May 2015
Two Labs, Many Methods
Michael Sattler
Published 28 April 2015
-
Picture This
Georgios Skiniotis
Published 20 March 2015
Intron Intrigue
Navtej Toor
Published 20 February 2015
-
Cut and Paste
Martin Jinek
Published 28 January 2015
Basics and Beyond
Qing Fan
Published 18 December 2014
-
Bloodletting and Other Studies
Pedro José Barbosa Pereira
Published 25 November 2014
Wire Models, Wired
A brief history of UCSF Chimera
Published 29 October 2014
-
In Search of…New Drugs
Doug Daniels
Published 30 September 2014
An Affinity for Affinity…and Corals
John C. Williams
Published 29 August 2014
-
Pete Meyer, Ph.D.
Research Computing Specialist
Published 22 August 2014
Justin O'Connor
Sr. System Administrator
Published 20 August 2014
-
Carol Herre
Software Release Engineer
Published 15 August 2014
Elizabeth Dougherty
Science Writer
Published 13 August 2014
-
Andrew Morin, Ph.D.
Policy Research Fellow
Published 11 August 2014
Jason Key, Ph.D.
Associate Director of Technology and Innovation
Published 8 August 2014
-
Piotr Sliz, Ph.D.
Principal Investigator, SBGrid
Published 1 August 2014
New Kid on the Block
James Chen
Published 29 July 2014
-
Membrane Master
Tamir Gonen
Published 30 June 2014
The Natural Bridge
Piotr Sliz
Published 13 June 2014
-
Surprise, Surprise
Catherine Drennan
Published 26 April 2014
Gone Viral
Olve Peersen
Published 20 March 2014
-
All Who Wander Are Not Lost
Frank Delaglio
Published 24 February 2014
The Raw and the Cooked
Graeme Winter
Published 24 January 2014
-
Vacc-elerator
Peter Kwong
Published 17 December 2013
Structural Storyteller
Karin Reinisch
Published 15 November 2013
-
The Fixer
Jane Richardson
Published 28 October 2013
Inside the Box
Mishtu Dey
Published 17 September 2013
-
Sensing a Change
Brian Crane
Published 16 August 2013
Towards Personalized Oncology
Mark Lemmon
Published 16 July 2013
-
Brush with Fame
Yizhi Jane Tao
Published 14 June 2013
Toxic Avenger
Borden Lacy
Published 21 May 2013
-
Pushing the Boundaries
Stephen Harrison
Published 22 April 2013
Strength in Numbers
Joseph Ho
Published 18 March 2013
-
One Lab, Many Methods
Wesley Sundquist
Published 12 February 2013
Unplanned Pioneer
Tim Stevens
Published 15 January 2013
-
From Actin to Action
Emil Pai
Published 11 January 2013
Unstructured
A Brief History of CCP4
Published 12 December 2012
-
Stop, Collaborate and Listen
Eleanor Dodson
Published 5 November 2012
X-PLORer
Axel Brunger
Published 1 October 2012
-
Share the Wealth
Zbyszek Otwinowski
Published 22 August 2012
Unraveling RNA
Anna Pyle
Published 18 July 2012
-
Sharper Image
Pawel Penczek and SPARX
Published 4 June 2012
Creative Copy Cat
Pamela Bjorkman
Published 25 April 2012
-
Charm and Diplomacy
Gerard Kleywegt
Published 7 March 2012
From Curiosity to Cure
Marc Kvansakul
Published 13 December 2011
-
The Lure of the Sandbox
Paul Emsley and Coot
Published 15 October 2011
Springsteen, Tolkien, Protein
Alwyn Jones and Frodo
Published 17 June 2011
-
Structures Solved Simply
Paul Adams and Tom Terwilliger on Phenix
Published 2 June 2011
Escape from the Darkroom
Wolfgang Kabsch and XDS
Published 19 May 2011
-
Playing the Odds
Randy Read and Phaser
Published 19 May 2011
Better, Faster, Stronger, More
Victor Lamzin and ARP/wARP
Published 17 May 2011
-
Crystallography for Kids
Lynne Howell
Published 17 May 2011
Side-Track to Success
Ning Zheng
Published 13 May 2011